Whoop says FDA is 'overstepping its authority' with warning about blood pressure feature

cnbc.com/2025/07/15/whoop-fda-blood-pressure-feature-wearables.html

The U.S. Food and Drug Administration on Tuesday published a warning letter addressed to the wrist wearable company Whoop, alleging it is marketing a new blood pressure feature without proper approvals.
The letter centers around Whoop's Blood Pressure Insights (BPI) feature, which the…

This story appeared on cnbc.com, 2025-07-15 21:08:33.
The Entire Business World on a Single Page. Free to Use →